publication venue for
- Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows.. 65. 2024
- The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation.. 65. 2024
- Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry").. 65. 2023
- Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases.. 64. 2023
- Pulmonary involvement in catastrophic antiphospholipid syndrome: A descriptive analysis from the "CAPS Registry".. 63. 2023
- Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease.. 57. 2022
- Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs - Analysis of a national claims database.. 57. 2022
- Monosodium urate deposition in the lumbosacral spine of patients with gout compared with non-gout controls: A dual-energy CT study.. 56. 2022
- Consensus-driven conceptual development of a standardized whole body-MRI scoring system for assessment of disease activity in juvenile idiopathic arthritis: MRI in JIA OMERACT working group.. 51. 2021
- Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set. 2021
- Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial.. 51. 2021
- Thirty-day hospital readmission in systemic sclerosis associated pulmonary hypertension: A nationwide study.. 51. 2021
- Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis.. 51. 2021
- Racial and ethnic differences in medication use among beneficiaries of social security disability insurance with rheumatoid arthritis.. 50. 2020
- Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologists.. 50. 2020
- Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis.. 50. 2020
- Heart failure risk in systemic lupus erythematosus compared to diabetes mellitus and general medicaid patients.. 49. 2019
- The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.. 49. 2019
- Racial/Ethnic variations in morbidity and mortality in Adult Onset Still's Disease: An analysis of national dataset.. 49. 2019
- A better look at rheumatoid arthritis: Using imaging to improve patient outcomes.. 48. 2018
- A prospective study of obesity and risk of systemic lupus erythematosus (SLE) among Black women.. 48. 2018
- Racial/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus.. 48. 2018
- Arterial lesions in giant cell arteritis: A longitudinal study.. 48. 2018
- Rheumatoid arthritis and risk of chronic obstructive pulmonary disease or asthma among women: A marginal structural model analysis in the Nurses' Health Study.. 47. 2017
- Obesity and the risk of systemic lupus erythematosus among women in the Nurses' Health Studies.. 47. 2017
- Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study.. 47. 2017
- Pilot study of a multidisciplinary gout patient education and monitoring program.. 46. 2016
- Population-based study of outcomes of patients with juvenile idiopathic arthritis (JIA) compared to non-JIA subjects.. 46. 2016
- Patient preferences for total knee replacement surgery: Relationship to clinical outcomes and stability of patient preferences over 2 years.. 46. 2016
- Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.. 45. 2015
- Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients.. 43. 2013
- A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.. 40. 2010
- Case finding for population-based studies of rheumatoid arthritis: comparison of patient self-reported ACR criteria-based algorithms to physician-implicit review for diagnosis of rheumatoid arthritis.. 33. 2004
- Treatment of patients with advanced Paget's disease of bone with two cycles of gallium nitrate.. 23. 1994
- The effects of diclofenac sodium on arachidonic acid metabolism.. 15. 1985
- The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon.. 33. 2004
- Comment on "Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study". 2016
- The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group. 2020
- Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid. 2015
- Rheumatoid arthritis: Perioperative management of biologics and DMARDs. 2015
- Calcitonin in the treatment of transient osteoporosis of the hip. 2003
- Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group. 2022
- Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review. 2020
- Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis. 2006